Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. (Q35147482)

6 August 2017

title

Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. (English)

1 reference

6 August 2017

0 references

1 reference

1

Giovanni Latella

1 reference

6 August 2017

Silvia Speca

8

0 references

Christine Breynaert

object named as

Christine Breynaert

4

0 references

Gianluca Pellino

object named as

Gianluca Pellino

6

0 references

Gerhard Rogler

2

object named as

Gerhard Rogler

1 reference

6 August 2017

Giorgos Bamias

3

1 reference

6 August 2017

Jon Florholmen

5

1 reference

6 August 2017

Shimon Reif

7

1 reference

6 August 2017

Ian C Lawrance

9

1 reference

6 August 2017

publication date

14 April 2014

1 reference

Journal of Crohn's and Colitis

6 August 2017

published in

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

10

1 reference

6 August 2017

page(s)

1147-1165

1 reference

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Themes in fibrosis and gastrointestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Physiology of local renin-angiotensin systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Infectious disease, the innate immune response, and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Predictors of fibrostenotic Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

HMGB1 and RAGE in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Klotho in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

MicroRNAs in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Endoplasmic reticulum stress and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in response to endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: a role for SPARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

An alternate perspective on the roles of TIMPs and MMPs in pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Role of matrix metalloproteinases in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

The gut microbiome in intestinal fibrosis: environmental protector or provocateur?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Predominant role of host genetics in controlling the composition of gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

A new heterotopic transplant animal model of intestinal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Visceral fat and gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Adipose tissue and inflammatory bowel disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Mesenteric fat - control site for bacterial translocation in colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

PPARgamma as a new therapeutic target in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Identification of disease-associated DNA methylation in B cells from Crohn's disease and ulcerative colitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Molecular aspects of intestinal radiation-induced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.03.008

10.1016/J.CROHNS.2014.03.008

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference